Evidence map›Paper›PMID 31849641›Full record

ArticleFrontiers in pharmacology2019

C13 Megastigmane Derivatives From

San-Po Pan, Teresa Pirker, Olaf Kunert, Nadine Kretschmer, Scarlet Hummelbrunner, Simone L Latkolik, Julia Rappai, Verena M Dirsch, Valery Bochkov, Rudolf Bauer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Direct Organogenesis ofPlants (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Macrotranscriptomics analysis for decoding the role ofFrontiers in bioengineering and biotechnology · 2025
    Article
  4. Pharmaceutical biology · 2024
    Article
  5. Activity ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

San-Po PanDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
Teresa PirkerDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
Olaf KunertDepartment of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
Nadine KretschmerDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
Scarlet HummelbrunnerDepartment of Pharmacognosy, Molecular Targets, University of Vienna, Vienna, Austria.
Simone L LatkolikDepartment of Pharmacognosy, Molecular Targets, University of Vienna, Vienna, Austria.
Julia RappaiDepartment of Pharmacognosy, Molecular Targets, University of Vienna, Vienna, Austria.
Verena M DirschDepartment of Pharmacognosy, Molecular Targets, University of Vienna, Vienna, Austria.
Valery BochkovDepartment of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
Rudolf BauerDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
University of Graz · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to identify active constituents and to gain some information regarding their mode of action, extracts from leaves of

Indexed as

COX-2Epipremnum pinnatumgene expressionIL-8megastigmaneNF-κBβ-damascenone

Identifiers

PMID31849641
PMCPMC6892967
OpenAlexW2989563832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.